Search for: "Doe v. Abbott Laboratories" Results 61 - 80 of 205
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Nov 2015, 4:00 am by Alan Macek
If the Canadian patent office requires that a divisional application be filed pursuant to Section 36(2.1) of the Patent Act, a court has held that it would “be unfair and inequitable” (see Abbott Laboratories v. [read post]
14 Jan 2013, 4:30 am by Scott A. McKeown
Kappos) Last week the Federal Circuit heard oral argument (here) in Abbott Laboratories v. [read post]
13 Aug 2015, 10:56 am
  A change made through the CBE process does not require preapproval by the FDA. [read post]
14 Aug 2014, 5:14 am by Jon Hyman
Deborah Malin worked in the IT department of the Abbott Laboratories’s hospital product division (spun off to a new company, Hospira, in 2006). [read post]
13 Nov 2008, 1:52 pm
Abbott Laboratories, 607 P.2d 924, (Cal. 1980). [read post]
Abbott Laboratories, a unanimous three-judge panel ruled that it violates the Fourteenth Amendment’s Equal Protection Clause for a lawyer to “strike” (that is, remove) individuals from a jury panel on account of their sexual orientation. [read post]
26 May 2011, 7:37 am by Stefanie Levine
Background This case arose from a patent suit in which Abbott Laboratories and its subsidiary, Therasense (collectively “Abbott”) alleged that Becton, Dickinson & Co. and other parties (collectively, “BD”) had infringed Abbott’s patents relating to disposable blood glucose test strips. [read post]
29 Jun 2010, 10:43 am by Abbott & Kindermann
Abbott True to our standard annual mid-year update format, we are providing you with condensed summaries of each of the CEQA cases issued this year. [read post]
10 May 2024, 6:39 am by Rebecca Tushnet
Abbott Laboratories, No. 22-CV-5435 (RER) (JRC), 2024 WL 2022297 (E.D.N.Y. [read post]